Industry news
-
Breaking the Bottleneck in Obesity and Diabetes Treatment: The Remarkable Efficacy of Tirzepatide.
Tirzepatide is a novel dual GIP/GLP-1 receptor agonist that has shown great promise in the treatment of metabolic diseases. By mimicking the actions of two natural incretin hormones, it enhances insulin secretion, suppresses glucagon levels, and reduces food intake—effectively helping to control ...Read more -
Reduces Heart Failure Risk by 38%! Tirzepatide Is Reshaping the Landscape of Cardiovascular Treatment
Tirzepatide, a novel dual receptor agonist (GLP-1/GIP), has garnered significant attention in recent years for its role in the treatment of diabetes. However, its potential in cardiovascular and renal diseases is gradually emerging. Recent studies show that tirzepatide d...Read more -
Oral Semaglutide: A Needle-Free Breakthrough in Diabetes and Weight Management
In the past, semaglutide was primarily available in injectable form, which deterred some patients who were sensitive to needles or afraid of pain. Now, the introduction of oral tablets has changed the game, making medication more convenient. These oral semaglutide tablets use a special formulatio...Read more -
Retatrutide is revolutionizing the way obesity is treated
In today’s society, obesity has become a global health challenge, and the emergence of Retatrutide offers new hope for patients struggling with excess weight. Retatrutide is a triple receptor agonist targeting GLP-1R, GIPR, and GCGR. This unique multi-target synergistic mechanism demonstrat...Read more -
From Blood Sugar to Body Weight: Unveiling How Tirzepatide Is Reshaping the Treatment Landscape for Multiple Diseases
In the era of rapid medical advancement, Tirzepatide is bringing new hope to patients with various chronic diseases through its unique multi-target mechanism of action. This innovative therapy breaks through the limitations of traditional treatments and offers a safer, longer-lasting solution for...Read more -
The Health Benefits of GLP-1 Medications
In recent years, GLP-1 receptor agonists (GLP-1 RAs) have emerged as a key player in the treatment of diabetes and obesity, becoming an important part of metabolic disease management. These medications not only play a vital role in blood sugar control but also show remarkable effects in weight ma...Read more -
Semaglutide VS Tirzepatide
Semaglutide and Tirzepatide are two new GLP-1-based medications used for the treatment of type 2 diabetes and obesity. Semaglutide has demonstrated superior effects in reducing HbA1c levels and promoting weight loss. Tirzepatide, a novel dual GIP/GLP-1 receptor agonist, has also been approved by ...Read more -
What is Orforglipron?
Orforglipron is a novel type 2 diabetes and weight loss treatment drug under development and is expected to become an oral alternative to injectable drugs. It belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist family and is similar to the commonly used Wegovy (Semaglutide) and Mounja...Read more -
What are the differences between the raw material of semaglutide with 99% purity and that with 98% purity?
The purity of Semaglutide is critical to both its efficacy and safety. The main difference between Semaglutide API with 99% purity and 98% purity lies in the amount of active ingredient present and the potential level of impurities in the substance. The higher the purity, the greater the proporti...Read more -
What should I do if I don’t lose weight after using GLP-1 drugs?
What to do if you don’t lose weight on a GLP-1 medication? Importantly, patience is essential when taking a GLP-1 medication like semaglutide. Ideally, it takes at least 12 weeks to see results. However, if you don’t see weight loss by then or have concerns, here are some options to consider. Tal...Read more -
Tirzepatide: The guardian of cardiovascular health
Cardiovascular disease is one of the leading global health threats, and the emergence of Tirzepatide brings new hope for the prevention and treatment of cardiovascular conditions. This medication works by activating both GIP and GLP-1 receptors, not only effectively cont...Read more -
Insulin Injection
Insulin, commonly known as the “diabetes injection”, exists in everyone’s body. Diabetics do not have enough insulin and need additional insulin, so they need to receive injections. Although it is a type of medicine, if it is injected properly and in the right amount, the “...Read more